
    
      WATCHMAN FLX is intended to prevent thrombus embolization from the left atrial appendage and
      reduce the risk of life-threatening bleeding events in patients with non-valvular atrial
      fibrillation who are eligible for anticoagulation therapy or who have a contraindication to
      anticoagulation therapy.
    
  